Compare SAIC & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SAIC | BLLN |
|---|---|---|
| Founded | 1969 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.0B |
| IPO Year | N/A | 2025 |
| Metric | SAIC | BLLN |
|---|---|---|
| Price | $101.43 | $103.37 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 6 |
| Target Price | $115.13 | ★ $138.67 |
| AVG Volume (30 Days) | ★ 591.1K | 265.6K |
| Earning Date | 12-04-2025 | 12-09-2025 |
| Dividend Yield | ★ 1.46% | N/A |
| EPS Growth | ★ 33.04 | N/A |
| EPS | ★ 7.83 | N/A |
| Revenue | ★ $7,350,000,000.00 | $209,032,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.40 | N/A |
| P/E Ratio | $12.95 | ★ N/A |
| Revenue Growth | N/A | ★ 112.72 |
| 52 Week Low | $84.16 | $88.00 |
| 52 Week High | $133.00 | $138.70 |
| Indicator | SAIC | BLLN |
|---|---|---|
| Relative Strength Index (RSI) | 74.51 | N/A |
| Support Level | $85.20 | N/A |
| Resistance Level | $86.97 | N/A |
| Average True Range (ATR) | 2.64 | 0.00 |
| MACD | 1.42 | 0.00 |
| Stochastic Oscillator | 84.50 | 0.00 |
Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.
BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.